References
- Michel R B, Mattes M J. Antibodies to CD20 and MHC class II antigen bound to B-lymphoma cells accumulate in shed cytoplasmic fragments. Br J Cancer 2004; 91: 1500–1507
- McLaughlin P, Grillo-Lopez A J, Link B K, Levy R, Czuczman M S, Williams M E, et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 1998; 16: 2825–2833
- Brown K S, Levitt D J, Shannon M, Link B K. Phase II trial of Remitogen (humanized 1D10) monoclonal antibody targeting class II in patients with relapsed low-grade or follicular lymphoma. Clin Lymphoma 2001; 2: 188–190
- Kennedy A D, Beum P V, Solga M D, DiLillo D J, Lindorfer M A, Hess C E, et al. Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia. J Immunol 2004; 172: 3280–3288
- Söderström N. The free cytoplasmic fragments of lymphoglandular tissue (lymphoglandular bodies). Scand J Immunol 1968; 5: 138–152
- Ran S, He J, Huang X, Soares M, Scothorn D, Thorpe P E. Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice. Clin Cancer Res 2005; 11: 1551–1562
- Hansen H J, Ong G L, Diril H, Roche P A, Griffiths G L, Goldenberg D M, et al. Internalization and catabolism of radiolabeled antibodies to the MHC class II invariant chain by B-cell lymphomas. Biochem J 1996; 320: 293–300
- Ong G L, Mattes M J. Processing of antibodies to the MHC class II antigen by B-cell lymphomas: release of Fab-like fragments into the medium. Mol Immunol 1999; 36: 777–788
- Michel R B, Mattes M J. Intracellular accumulation of the anti-CD20 antibody 1F5 in B-lymphoma cells. Clin Cancer Res 2002; 8: 2701–2713
- Nagy Z A, Hubner B, Löhning C, Rauchenberger R, Reiffert S, Thomassen W E, et al. Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells. Nature Med 2002; 8: 801–807
- Nagy Z A, Mooney N A. A novel, alternative pathway of apoptosis triggered through class II major histocompatibility complex molecules. J Mol Med 2003; 81: 757–765
- Escola J M, Kleijmeer M J, Stoorvogel W, Griffith J M, Yoshie O, Geuze H J. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 1998; 273: 20121–20127
- Schreiner G F, Unanue E R. Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction. Adv Immunol 1976; 24: 37–165
- Loor F. Plasma membrane and cell cortex interactions in lymphocyte functions. Adv Immunol 1980; 30: 1–120
- Pulczynski S, Boesen A M, Jensen O M. Modulation and intracellular transport of CD20 and CD21 antigens induced by B1 and B2 monoclonal antibodies in Raji and JOK-1 cells – an immunofluorescence and immunoelectron microscopy study. Leukemia Res 1994; 18: 541–552
- Léveillé C, Reem A D, Mourad W. CD20 is physically and functionally coupled to MHC class II and CD40 on human B cell lines. Eur J Immunol 1999; 29: 65–74
- Verhoven B, Schlegel R A, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995; 182: 1597–1601
- Dillon S R, Mancini M, Rosen A, Schlissel M S. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol 2000; 164: 1322–1332
- Cocca B A, Cline A M, Radic M Z. Blebs and apoptotic bodies are B cell autoantigens. J Immunol 2002; 169: 159–166
- Heijnen H FG, Schiel A E, Fijnheer R, Geuze H J, Sixma J J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and a-granules. Blood 1999; 94: 3791–3799
- Cardarelli P M, Quinn M, Buckman D, Fang Y, Colcher D, King D J, et al. Binding to CD20 by anti-B1 antibody or F (ab′)2 is sufficient for induction of apoptosis in B-cell lines. Cancer Immunol Immunother 2002; 51: 15–24
- Chan H T, Hughes D, French R R, Tutt A L, Walshe C A, Teeling J L, et al. CD20-induced lymphoma cell death is independent of both caspases and its redistribution into Triton-X100 insoluble membrane rafts. Cancer Res 2003; 63: 5480–5489
- Shan D, Ledbetter J A, Press O W. Apoptosis of malignant B cells by ligation of CD20 with monoclonal antibodies. Blood 1998; 91: 1644–1652